ArriVent BioPharma appoints Dr. Hohneker to two board committees

ArriVent BioPharma, Inc.

Dr. John Hohneker appointed to Nominating and Corporate Governance Committee, effective July 3, 2024.
Also appointed to Compensation Committee of the Board, effective same date.
Amendment corrects omission from original May 16, 2024 8-K reporting his director election.

item 5.02

ArriVent BioPharma, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-078587

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.